FIELD: veterinary science. SUBSTANCE: method involves the use of the preparation of interleukin-1 that stimulates the protective functions of organism. Preparation is administrated intravenously, intraperitoneally or subcutaneously at doses 0.000001-0.01 mg/kg animal mass. EFFECT: enhanced effectiveness. 5 cl
| Title | Year | Author | Number |
|---|---|---|---|
| WOUND-HEALING COMPOSITION | 1993 |
|
RU2122401C1 |
| CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
| IMMUNOMODULATING PREPARATION "BETALEUKIN" | 1998 |
|
RU2128706C1 |
| THERAPEUTIC AGENT AND METHOD FOR PREVENTION OF HIV INFECTION AND TREATMENT OF HIV-CAUSED OR HIV-ASSOCIATED DISEASES, INCLUDING AIDS | 2010 |
|
RU2535033C2 |
| METHOD FOR TREATMENT AND PREVENTION OF PARASITOSIS OF BIRDS WITH OPTIMIZATION OF THEIR METABOLISM AND NATURAL RESISTANCE | 2018 |
|
RU2694546C1 |
| PREVENTION AND TREATMENT OF CRYPTOSPORIDIOSIS IN CALVES | 2008 |
|
RU2391992C1 |
| DRUG FOR RESPIRATORY INFECTIOUS DISEASES GLUCAFERON | 2011 |
|
RU2450812C1 |
| METHOD FOR PREVENTION AND TREATMENT OF CHRONIC, FREQUENTLY RECURRENT HERPES VIRUS INFECTION | 2008 |
|
RU2373951C1 |
| METHOD FOR PROGNOSIS OF TREATMENT EFFECTIVENESS WITH RECOMBINANT CYTOKINE REGULATING INFLAMMATION | 2004 |
|
RU2271827C1 |
| PEPTIDE POSSESSING ANTIATHEROSCLEROTIC ACTION AND COMPOSITION FOR PREVENTING AND TREATING ATHEROSCLEROTIC VASCULAR DISEASE | 2012 |
|
RU2495048C1 |
